Clinical Trials Browser

Unknown × Graft vs Host Disease × Other hematologic neoplasm × Clear all

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Motor Activity, Hematologic Neoplasms

NCT04688021 2023-02-21

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Phase 2 Unknown

46 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Leukemia

NCT03533816 2023-02-08

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Phase 1 Unknown

38 enrolled

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04033627 2022-09-29

TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

Phase NA Unknown

30 enrolled

LymphoidOther hematologic neoplasm

Disease, Graft vs Host Disease, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05158608 2022-01-11

CY25

Phase 3 Unknown

100 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT04622956 2021-09-14

GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide

Phase 1/2 Unknown

47 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT03836690 2019-10-25

ToTem

Phase 1 Unknown

18 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Primary Immunodeficiency Diseases, Anemia, Aplastic, Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT01240525 2019-02-12

ProT4

Phase 2 Unknown

114 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile

NCT02185261 2018-06-07

Interferon α for the Therapy of Minimal Residual Disease

Phase NA Unknown

81 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Leukemia, Recurrence, Neoplasm, Residual

NCT03148197 2017-07-19

COLLECT

Unknown

120 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Leukemia, Myeloid, Acute

NCT00524784 2015-06-11

Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Phase 1/2 Unknown

12 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT00679536 2014-01-23

Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors

Phase 1/2 Unknown

30 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Leukemia

NCT00093587 2013-11-06

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Phase NA Unknown

Other hematologic neoplasm

Congenital Abnormalities, Graft vs Host Disease, Leukemia

NCT00462657 2013-08-26

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

Phase NA Unknown

200 enrolled

LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Graft vs Host Disease, Infections, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT00740467 2010-01-28

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Phase 2 Unknown

50 enrolled

DermatologicLymphoidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Precancerous Conditions, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Clinical Trials

Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

CY25

GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide

ToTem

ProT4

Interferon α for the Therapy of Minimal Residual Disease

COLLECT

Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders